Evidence map›Paper›PMID 30514784›Full record

ArticlemBio2018

Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.

Olga Musharova, Danylo Vyhovskyi, Sofia Medvedeva, Jelena Guzina, Yulia Zhitnyuk, Marko Djordjevic, Konstantin Severinov, Ekaterina Savitskaya

Abstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Detection of CRISPR adaptation.Biochemical Society transactions · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olga Musharova *Center for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Danylo Vyhovskyi *Center for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Sofia MedvedevaCenter for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Jelena GuzinaInstitute of Physiology and Biochemistry, Faculty of Biology, University of Belgrade, Belgrade, Serbia.
Yulia ZhitnyukCenter for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Marko DjordjevicInstitute of Physiology and Biochemistry, Faculty of Biology, University of Belgrade, Belgrade, Serbia.
Konstantin SeverinovCenter for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia severik@waksman.rutgers.edu.
Ekaterina SavitskayaCenter for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.

Funding

The Function of Small RNA-Based viral Defense System in E. coli - Renewal 1R01GM104071 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI SEMENOVA, EKATERINA · 2013 to 2024
$3.9M
NIGMS NIH HHS R01 GM104071
6 · The paper itself

Abstract

CRISPR DNA arrays of unique spacers separated by identical repeats ensure prokaryotic immunity through specific targeting of foreign nucleic acids complementary to spacers. New spacers are acquired into a CRISPR array in a process of CRISPR adaptation. Selection of foreign DNA fragments to be integrated into CRISPR arrays relies on PAM (protospacer adjacent motif) recognition, as only those spacers will be functional against invaders. However, acquisition of different PAM-associated spacers proceeds with markedly different efficiency from the same DNA. Here, we used a combination of bioinformatics and experimental approaches to understand factors affecting the efficiency of acquisition of spacers by the

Indexed as

CRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsDNA, BacterialDNA, IntergenicEscherichia coliDNA, BacterialDNA, IntergenicCRISPR-CasCRISPR spacersnaïve adaptationprimed adaptation

Identifiers

PMID30514784
PMCPMC6282206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.